Founding investor Lundbeckfonden Emerge returned to co-lead a series A round for the gene editing drug developer with Life Science Partners.

Natiowide has taken a minority stake in financial services portal developer 10x Future Technologies through a $16.9m series B investment.

JLL Spark's $100m Global Venture Fund has appointed Concrete VC to source real estate technology investment opportunities in the EMEA region.

The Cambridge spinout plans to build out the business for its automated customer support platform after collecting $12m in series A funding.

Gyroscope Therapeutics recently commenced phase 1/2 clinical trials on a retinal gene therapy for dry age-related macular degeneration.

Anaveon emerged out of University of Zurich in late 2017 with the support of Novartis-backed UZH Life Sciences Fund and the corporate has now also invested directly.

Honda and existing investors EDF and Siemens all contributed to a $22.7m round that will fund the expansion of Ubitricity's EV charging network.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Rabobank has contributed to Gilde Healthcare’s third private equity fund, which will focus on established and profitable businesses in the Benelux and Dach countries.

Digital insurance startup Friday has pulled in funding from majority shareholder Baloise as well as SevenVentures and German Media Pool.